Maglasang, Ronel T.
HRN: 23-95-35 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2023
CEFUROXIME 750MG (VIAL)
10/25/2023
11/01/2023
IV
500mg
TID
Uti
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Urinary TractBloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes